NCT00038675
- Conditions
- Bone Marrow Diseases, Bone Marrow Neoplasms, Chronic Disease, +26 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Hypereosinophilic Syndrome
Explore clinical trials studying Hypereosinophilic Syndrome. Study availability and eligibility vary by location and protocol.
20 public trials
5 recruiting studies
Hypereosinophilic Syndrome trial results
NCT00109707
- Conditions
- Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Bone Marrow Diseases, Chronic Disease, +27 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Colorado Hospital Aurora, Colorado, United States
- H. Lee Moffitt Cancer Center & Research Institute Dept.of H. Lee Moffitt Tampa, Florida, United States
NCT03306043
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- GSK Investigational Site La Jolla, California, United States
- GSK Investigational Site New Haven, Connecticut, United States
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Cincinnati, Ohio, United States
NCT00086658
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Bethesda, Maryland, United States
- GSK Investigational Site Boston, Massachusetts, United States
Completed
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
NCT02836496
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- GSK Investigational Site San Diego, California, United States
- GSK Investigational Site New Haven, Connecticut, United States
- GSK Investigational Site Rochester, Minnesota, United States
- GSK Investigational Site Cincinnati, Ohio, United States
NCT00171912
- Conditions
- Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +32 more
- Locations
-
- Novartis Investigative Site East Melbourne, Australia
NCT00787384
- Conditions
- Chronic Eosinophilic Leukemia, Chronic Idiopathic Hypereosinophilia, Eosinophilia, +5 more
- Locations
-
- USC Ematologia Ospedali Riuniti di Bergamo Bergamo, Italy
- Divisione di Ematologia Spedali Civili di Brescia Brescia, Italy
- USC Ematologia Azienda Ospedaliera Università Careggi Florence, Firenze, Italy
- UO Ematologia, Azienda Ospedaliera ULSS6 Vicenza, Italy
NCT00017862
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States
Active, Not Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)
NCT04191304
- Conditions
- Eosinophilia, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
- Locations
-
- Research Site La Jolla, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Bethesda, Maryland, United States
- Research Site Ann Arbor, Michigan, United States
Active, Not Recruiting
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
NCT00044304
- Conditions
- Eosinophilia, Eosinophilic Myeloid Neoplasm, Hematologic Diseases, +3 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States